A Comprehensive Report for decision making
Drug Developer's Intelligence Report
Oncology DRUG REPORT
2020
This Report is only Available on request...
This Report is only Available on request...
Kindly Check the Latest Updated Report of this Series
Kindly Check the Latest Updated Report of this Series
RELEASED - FEB 2020
It is an excellent report that has a wide variety of oncology information all in one place.
- Dr. Oleh Denysyk
OI 2020 Vs OI 2017
(in terms of Oncology Drug Developers Number)
UPDATED DATA for
ACCURATE DECISIONS
ODR 2020 is a key update over previous report OI 2017, as it may covers 220 more oncology drug developers than the previous report. It also abandoned 103 companies, which were earlier covered in OI 2014, which were either acquired/merged or closed during the period.
largest coverage
providing intelligence at fingertips
1
Countries
Largest Coverage with 32 Countries covered Globally
1
Drug developers
523 Clinical, 360 Preclinical Companies Profiles
1
+
Molecules
Individual Drug Mechanism of Action & Drug Target
1
+
Cancer Targets
Emerging Cancer Drug Targets Details
intelligence supercharged
1055 pages full of insights
Other Reports in this series
Oncology Intelligence 2013
Comprehensive Decision Making Intelligence derived from Active 624 Oncology Drug Developers.
Oncology Drug Report 2014
Comprehensive Decision Making Intelligence derived from Active 931 Oncology Drug Developers.
Oncology Drug Report 2017
Comprehensive Decision Making Intelligence derived from Active 1047 Oncology Drug Developers.
Oncology Drug Report 2020
Comprehensive Decision Making Intelligence derived from Active 1610 Oncology Drug Developers.
Oncology Drug Report 2021
Comprehensive Decision Making Intelligence derived from Active 2010 Oncology Drug Developers.
Oncology Drug Report 2022
Upcoming Comprehensive Decision Making Report derived from Active 2300+ Oncology Drug Developers.